Boan Biotech Begins International Phase III Trial Of Denosumab Biosimilars

One Product Is Already Approved For Marketing In China

US, EU and Japanese flags
The international study has been initiated in Europe, the US and Japan • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin